MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$3,237,969
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from the issuance o...
Net proceeds from the issuance o...
Accounts payable and accrued lia...
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-04-30
Net loss
-8,772,382
Depreciation expense
110,740
Stock-based compensation to employees, directors and consultants
707,527
Prepaid expenses and other current assets
825,089
Accounts payable and accrued liabilities
711,391
Net cash used in operating activities
-8,067,813
Net proceeds from the issuance of common stock
794,844
Net proceeds from the issuance of preferred stock
4,035,000
Net cash provided by financing activities
4,829,844
Net (decrease) increase in cash
-3,237,969
Cash at beginning of period
3,948,658
Cash at end of period
710,689
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
the issuance of...
$4,035,000
Net proceeds from
the issuance of...
$794,844
Net cash provided by
financing activities
$4,829,844
Net (decrease)
increase in cash
-$3,237,969
Canceled cashflow
$4,829,844
Accounts payable and
accrued liabilities
$711,391
Stock-based compensation to
employees, directors and...
$707,527
Depreciation expense
$110,740
Net cash used in
operating activities
-$8,067,813
Canceled cashflow
$1,529,658
Net loss
-$8,772,382
Prepaid expenses and
other current assets
$825,089
Buy us a coffee
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)